Quick Facts
- Sample: Blood draw
- Fasting: Generally not required
- Turn-around: 3–7 business days. May take longer based on weather, holiday, or lab delays.
Benefits
- Assess fertility potential without physician referral or appointment delays
- Evaluate ovarian reserve with superior AMH testing (80% sensitivity vs 28% for FSH)
- Identify hormonal imbalances affecting conception and menstrual irregularities
- Plan pregnancy timing with comprehensive hormone analysis and baseline assessment
- Save money with direct-access testing significantly less than traditional clinic visits
- Get private results through secure online portals with optional physician consultation
Who Is This Test For?
- Women planning future pregnancies who want baseline fertility assessment
- Individuals with irregular menstrual cycles or absent periods
- Couples trying to conceive for 6+ months (over 35) or 12+ months (under 35)
- Those considering IVF who need pre-treatment hormone evaluation
- Women over 35 monitoring age-related fertility decline
- Anyone seeking proactive reproductive health insights
How It Works – Just 3 Steps
- Schedule your blood draw at any of 4,000+ certified collection sites nationwide
- Provide blood sample during a quick 5-10 minute visit (timing matters for some hormones)
- Access results online within 3-7 days through secure portal
FAQ
What hormones are included in this panel? The panel measures AMH, FSH, LH, Estradiol, Progesterone, Prolactin, and TSH to evaluate fertility potential.
Do I need to time the test with my menstrual cycle? AMH can be tested any day, but FSH and Estradiol require Day 2-3 of your cycle for accuracy.
How accurate is AMH testing for fertility assessment? AMH demonstrates 80% sensitivity and 78% specificity for ovarian reserve, superior to FSH testing.
Can I get this test without a doctor's referral? Yes, this is direct-to-consumer testing with no physician referral required for convenient access.
What if my results show abnormal hormone levels? Abnormal results warrant consultation with a reproductive endocrinologist for personalized treatment planning.
More Details
What is the purpose of this test?
This comprehensive fertility hormone panel evaluates reproductive hormone levels to assess fertility potential, ovarian reserve, and ovulation patterns. The test measures key hormones including Anti-Müllerian Hormone (AMH), Follicle-Stimulating Hormone (FSH), Luteinizing Hormone (LH), Estradiol, Progesterone, Prolactin, and Thyroid-Stimulating Hormone (TSH) that directly regulate ovarian function and egg development (American College of Obstetricians and Gynecologists 2023).
Results provide insights into egg quantity, ovulation timing, and potential hormonal imbalances affecting conception. This testing helps identify issues early, enabling informed family planning decisions and determining the need for specialist consultation (Mayo Clinic Fertility Testing Laboratory 2025).
Who would benefit from this test?
Women planning pregnancy benefit from baseline fertility assessment before age-related decline. Individuals with irregular menstrual cycles can identify underlying hormonal causes affecting reproduction. Couples trying to conceive for 6-12 months gain valuable insights into fertility potential without clinic visits.
This testing particularly benefits women over 35 monitoring reproductive health, those considering future IVF treatment, and anyone seeking proactive fertility evaluation. The direct-access model provides convenience and privacy for comprehensive hormone assessment (CDC National Health Statistics 2024).
When should I order a Fertility Hormone Blood Test Panel?
Order testing after 6 months of trying to conceive if over 35, or 12 months if under 35, according to American College of OB/GYN guidelines. However, proactive testing is valuable anytime for baseline fertility assessment and family planning.
Consider testing if experiencing irregular cycles, planning future pregnancies, or wanting to understand reproductive health status. Early assessment helps identify potential issues before they impact conception efforts (American College of Obstetricians and Gynecologists 2023).
How do I interpret the results?
AMH (Anti-Müllerian Hormone): 1.0–3.0 ng/mL
– Indicates good ovarian reserve
FSH (Day 3): Less than 10 IU/L
– Suggests adequate ovarian function
Estradiol (Day 3): Less than 80 pg/mL
– Reflects normal baseline estrogen levels
LH (Luteinizing Hormone): Varies by menstrual cycle
– Signals normal ovulation process
Progesterone: Varies by menstrual cycle
– Confirms that ovulation has occurred
Prolactin: Less than 25 ng/mL
– Supports normal reproductive function
AMH levels are age-dependent and provide the most reliable indicator of ovarian reserve throughout the menstrual cycle.
Results should be reviewed with a healthcare provider for personalized interpretation based on age, cycle timing, and individual health factors (Cleveland Clinic Reproductive Medicine 2025).
Disclaimer: Reference ranges may vary by laboratory. Listed ranges are general guidelines and may differ from those used by the performing lab. Always consult your healthcare provider for interpretation.
Pre-test preparation
Schedule blood draw on Day 2-3 of menstrual cycle for FSH, LH, and Estradiol testing accuracy. AMH can be tested any day as levels remain stable throughout the cycle.
Fasting is generally not required except possibly for prolactin testing. Stay hydrated, eat normally, and avoid medications that may affect hormone levels unless medically necessary. Schedule morning appointments when possible for consistent hormone level measurement.
How often should I get tested?
- Baseline fertility assessment: Test once for initial evaluation
- Women over 35 planning pregnancy: Test annually
- Borderline or inconsistent results: Repeat testing in 3–6 months
- Monitoring fertility treatments: Test as directed by a fertility specialist
- PCOS or hormonal disorders: Test every 6–12 months
Why early detection matters
Early fertility hormone assessment enables proactive family planning before age-related decline impacts conception. Since infertility affects 13.4% of women ages 15-49, early detection identifies correctable issues and optimizes reproductive timing (CDC 2024).
Female fertility declines significantly after age 35, making baseline hormone evaluation crucial for informed reproductive decisions. Early intervention can address hormonal imbalances, lifestyle factors, and treatment options to maximize fertility potential.
Related tests you may consider
CBC and CMP-14 Blood Test Panel – Combines two essential panels to evaluate overall health. The CBC checks red and white blood cells and platelets, while the CMP-14 assesses kidney and liver function, blood sugar, electrolytes, and protein levels.
Anti-Mullerian Hormone (AMH) Blood Test (Female Only) – Measures AMH levels to help assess ovarian reserve, fertility potential, and response to fertility treatments. Often used in evaluating reproductive health and conditions like PCOS.
Hormone Clinic Profile, Women – Offers a comprehensive evaluation of female hormone levels, including Estradiol, Progesterone, FSH, LH, DHEA-S, and Total and Free Testosterone, to help assess menstrual irregularities, fertility concerns, menopausal symptoms, and overall hormonal balance.
